Clinical validation for this axis comes from the work of Katakura et al., who demonstrated a significant inverse correlation between miR-200b and PD-L1 tumor proportion score (TPS) in both tumor cells and serum-derived exosomes from NSCLC patients. Here, CD274 is linked to neoplasm.